drugset / Trial / NCT00348582

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

NCT00348582 ↗

Phase 4 Completed Innovative Medical
RandomizedParallel-groupSingle-blind

Summary

The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified — —
Subject Nepafenac Other / unclassified — —

Indications